{"id":"W2620097568","doi":"10.1016/j.jtho.2017.05.019","title":"Scientific Advances in Thoracic Oncology 2016","year":2017,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Foundation Medicine; Loxo Oncology; Pharmacyclics; Chugai Pharmaceutical; EMD Serono; Genentech; Medela; Astellas Pharma; Daiichi-Sankyo; Taiho Pharmaceutical; National Institutes of Health; Regeneron Pharmaceuticals; Meiji Seika Pharma; American Cancer Society; Shionogi; Helsinn; Mirati Therapeutics; Clovis Oncology; Varian Medical Systems; Ariad Pharmaceuticals; Cancer Research UK; Array BioPharma; National Cancer Institute; Gilead Sciences; Exelixis; Sanofi; G1 Therapeutics; Celgene; AstraZeneca; Ignyta; Eli Lilly and Company; Bristol-Myers Squibb; Pfizer","keywords":"Medicine; Lung cancer; Targeted therapy; Immunotherapy; Oncology; Radiation therapy; Internal medicine; Radiation oncology; Medical physics; Cancer; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007868292,0.0009408246,0.001675709,0.002934148,0.0003318292,0.001813196,0.0007730401,0.001367778,0.009742616],"category_scores_gemma":[0.001861405,0.000392795,0.0006763007,0.002742109,0.0004829146,0.001804211,0.001241523,0.002333564,0.003592604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008435827,"about_ca_system_score_gemma":0.002335836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001180637,"about_ca_topic_score_gemma":0.003456978,"domain_scores_codex":[0.9997147,0.00004646834,0.0000674058,0.00004092726,0.00009640409,0.00003406285],"domain_scores_gemma":[0.9992478,0.0003237636,0.0001482731,0.00002039747,0.0001758898,0.00008372181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001016759,0.0000483679,0.0002223282,0.02652268,0.0001285693,0.0001470754,0.0000504352,0.0002946465,0.0007834232,0.001978026,0.06821743,0.9015054],"study_design_scores_gemma":[0.00004599977,0.00005774601,0.0007299558,0.01000655,0.0003541652,0.0007222067,0.00005473319,0.00008378359,0.0001846453,0.001305824,0.9864348,0.00001959132],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007234827,0.9969013,0.00009799678,0.0006236472,0.0008136466,0.000008421212,0.0000425413,0.0000110987,0.001429046],"genre_scores_gemma":[0.0005944376,0.9968638,0.0001933993,0.0006906845,0.000681041,0.000007748895,0.0000573608,0.000002357024,0.0009091938],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009742616,"threshold_uncertainty_score":0.0325923,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09726148855054398,"score_gpt":0.5912693878452375,"score_spread":0.4940078992946936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}